Article
Sex and ApoE genotype differences in treatment response to two doses of intranasal insulin in adults with mild cognitive impairment or Alzheimer's disease.
Journal of Alzheimer's disease : JAD - 1 Jan 2013
Claxton Amy, Baker Laura D, Wilkinson Charles W, Trittschuh Emily H, Chapman Darla, Watson G Stennis, Cholerton Brenna, Plymate Stephen R, Arbuckle Matthew, Craft Suzanne
Abstract excerpt
A previous clinical trial demonstrated that four months of treatment with intranasal insulin improves cognition and function for patients with Alzheimer's disease (AD) or mild cognitive impairment (MCI), but prior studies suggest that response to insulin treatment may differ by sex and ApoE ε4 ca...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
